Thekkemadom Ramakrishnan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2925 William Penn Highway, Suite # 303, Easton, PA 18045 Phone: 610-559-9622 |
News Archive
Researchers say on a daily basis around 275 Australians develop type 2 diabetes and worldwide, every 30 seconds a person somewhere has a lower limb amputated because of diabetic foot disease.
Researchers may have found a more potent risk factor for melanoma than blistering sunburns, freckling, or family history of the deadly skin disease.
Stem cells taken from muscle tissue could promote better blood flow in patients with diabetes who develop peripheral artery disease, a painful complication that can require surgery or lead to amputation.
Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient has been dosed with the companies' long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in a global registrational clinical trial. The study, called A-LONG, is an open-label, multicenter, Phase 2/3 study designed to evaluate the safety, pharmacokinetics and efficacy of rFVIIIFc in previously-treated hemophilia A patients.
Beike Biotechnology Co. Ltd., one of the world's leading biotechnology companies focusing on adult stem cell therapies, has been awarded ISO9001 certification by the International Organization for Standardization ("ISO"). This internationally recognized designation signifies Beike has established a Quality Management System (QMS) that complies with ISO9001 standards.
› Verified 9 days ago